MGI Demonstrates Success of New CoolMPS™ Sequencing Chemistry on PCR-free DNBSEQ™ Platform
2019-10-18
MGI, a subsidiary of global genomics leader BGI Group, said early research results from its revolutionary CoolMPS™ proprietary sequencing technology performed with high accuracy, reproducibility and cost effectiveness, leading the way toward more efficient and accurate Massively Parallel Sequencing (MPS). MGI also reported that its DNBSEQ-T7 genetic sequencer, the world's most powerful, was successfully delivered to multiple customers in China.
More
